EBAC
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
EBAC
Delisted
EBAC was delisted on the 2nd of March, 2023.
45 hedge funds and large institutions have $69.6M invested in European Biotech Acquisition Corp. Class A Ordinary Shares in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
+4
Holders Change %
+9.76%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
1
Closed
2
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
–
Top Buyers
1 |
HP
Hartree Partners
New York
|
+$7.49M |
2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$4.5M |
3 |
D.E. Shaw & Co
New York
|
+$1.6M |
4 |
AMH
Apollo Management Holdings
New York
|
+$967K |
5 |
![]()
Marshall Wace
London,
United Kingdom
|
+$852K |
Top Sellers
1 |
AC
Athanor Capital
New York
|
-$1.43M |
2 |
Millennium Management
New York
|
-$87.3K |
3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$4K |